Validations: Exception Handling & Rework Controls
Mock Recalls Using Serialization Data Mock Recalls Using Serialization Data The pharmaceutical industry is under increasing pressure to ensure compliance with regulations surrounding serialization, aggregation, and data integrity. One effective method to validate processes is through mock recalls utilizing serialization data. This comprehensive guide presents a step-by-step approach to designing a serialization and aggregation program that complies with regulations such…
Complaint Handling Linked to Serial Data Complaint Handling Linked to Serial Data Introduction to Serialization and Aggregation in Pharmaceuticals In the modern pharmaceutical landscape, ensuring the integrity of supply-chain data is paramount. Serialization and aggregation play critical roles in complying with regulatory standards such as the DSCSA in the United States and the EU FMD requirements. As pharmaceutical companies implement…
Exception Metrics: FNR, Rework Rate, and Cycle Time In the increasingly complex world of pharmaceutical serialization and aggregation, understanding the metrics related to exception handling and rework is critical. This comprehensive tutorial aims to provide a step-by-step guide to developing exception metrics, focusing on FNR (Failure Noted Ratio), rework rate, and cycle time. The content is aligned with current regulatory…
Partner Errors: How to Investigate and Close Partner Errors: How to Investigate and Close Understanding Serialization and Its Importance in Pharma Serialization is a critical component in the pharmaceutical industry, ensuring that each product is uniquely identifiable throughout the supply chain. This process not only enhances traceability but also supports compliance with regulations such as the DSCSA in the U.S….
Mixed-Case Exceptions: Splits and Merges Mixed-Case Exceptions: Splits and Merges In the pharmaceutical industry, effective serialization and aggregation processes are essential for regulatory compliance and ensuring product integrity throughout the supply chain. The management of mixed-case exceptions, such as splits and merges, is critical to maintaining data accuracy and adherence to standards like the Drug Supply Chain Security Act (DSCSA)…
GS1 Rules in Edge Cases: What’s Allowed GS1 Rules in Edge Cases: What’s Allowed In the ever-evolving landscape of pharmaceutical serialization and aggregation, it is crucial for industry professionals to understand the nuances associated with the General Standard 1 (GS1) rules, particularly when faced with edge cases. These edge cases often arise from unique challenges within serialization URS, master data…
Quarantine and Hold Rules in Serialized Flow The pharmaceutical industry is increasingly dependent on serialization and aggregation strategies to enhance traceability, compliance, and supply chain integrity. Serialization Under Requirements Specification (URS) is pivotal in articulating the specifications necessary for successful implementation of serialization and aggregation systems. This article provides a comprehensive guide on quarantine and hold rules within serialized flows,…
Quarantine and Hold Rules in Serialized Flow The implementation of serialization and aggregation in pharmaceutical supply chains is a critical requirement mandated by regulatory bodies such as the US FDA, EMA, and MHRA. These guidelines ensure that drugs are properly tracked, authenticated, and accounted for throughout their lifecycle. This article serves as a comprehensive tutorial on quarantine and hold rules…
Expired/Lot Change Overs: Exception Handling Expired/Lot Change Overs: Exception Handling In the pharmaceutical industry, ensuring the integrity and compliance of product serialization and aggregation are critical. As global regulations around drug serialization tighten, particularly under frameworks such as the US FDA’s Drug Supply Chain Security Act (DSCSA), the need for robust exception handling and rework controls becomes increasingly significant. This…
Expired/Lot Change Overs: Exception Handling Pharmaceutical businesses face numerous challenges related to serialization and aggregation, especially as they navigate the complex landscape of compliance with US FDA, EMA, and MHRA guidelines. One of the critical aspects of a robust serialization program is effectively managing expired and lot changeovers. This article provides a comprehensive step-by-step tutorial aimed at pharmaceutical professionals, including…